| scholarly article | Q13442814 |
| P50 | author | Michael Boeckh | Q56072917 |
| Keith R. Jerome | Q57904630 | ||
| Meei-Li Huang | Q61713476 | ||
| Brenda M Sandmaier | Q75025355 | ||
| P2093 | author name string | John A Hansen | |
| Danielle M Zerr | |||
| Joshua A Hill | |||
| Amalia S Magaret | |||
| Anna Mikhaylova | |||
| Ruth Hall-Sedlak | |||
| P2860 | cites work | The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro | Q28275318 |
| HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation | Q28727925 | ||
| Telomerase mutations in families with idiopathic pulmonary fibrosis | Q29615671 | ||
| Marek's disease virus: from miasma to model | Q33994187 | ||
| A population-based study of primary human herpesvirus 6 infection | Q34397270 | ||
| Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia | Q34409487 | ||
| Prevalence of chromosomally integrated human herpesvirus 6 in patients with human herpesvirus 6-central nervous system dysfunction | Q35627582 | ||
| Inherited chromosomally integrated human herpesvirus 6 as a predisposing risk factor for the development of angina pectoris | Q35818622 | ||
| Identification of chromosomally integrated human herpesvirus 6 by droplet digital PCR. | Q35879617 | ||
| Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the | Q35993314 | ||
| High HLA-DP Expression and Graft-versus-Host Disease | Q36028056 | ||
| Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation | Q36675947 | ||
| Efficient identification of inherited chromosomally integrated human herpesvirus 6 using specimen pooling | Q36689275 | ||
| Detection of Human Herpesvirus 6B (HHV-6B) Reactivation in Hematopoietic Cell Transplant Recipients with Inherited Chromosomally Integrated HHV-6A by Droplet Digital PCR. | Q36834718 | ||
| Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study | Q37022512 | ||
| Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation | Q37390571 | ||
| Chromosomally integrated human herpesvirus 6: questions and answers | Q37952634 | ||
| Human herpesvirus 6 and the nervous system. | Q38228553 | ||
| Roseoloviruses in transplant recipients: clinical consequences and prospects for treatment and prevention trials | Q38256992 | ||
| The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality | Q38956462 | ||
| Implications of Resident Memory T Cells for Transplantation | Q38996466 | ||
| Human telomeres that carry an integrated copy of human herpesvirus 6 are often short and unstable, facilitating release of the viral genome from the chromosome | Q39093058 | ||
| Detection of HHV-6-specific mRNA and antigens in PBMCs of individuals with chromosomally integrated HHV-6 (ciHHV-6). | Q40182260 | ||
| Human Herpesvirus 6B Induces Hypomethylation on Chromosome 17p13.3, Correlating with Increased Gene Expression and Virus Integration. | Q40290373 | ||
| Individuals with inherited chromosomally integrated human herpes virus 6 (ciHHV-6) have functionally active HHV-6 specific T-cell immunity. | Q40323692 | ||
| An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens | Q40483853 | ||
| Integration of human herpesvirus 6 in a Burkitt's lymphoma cell line | Q41006259 | ||
| Molecular and virological evidence of viral activation from chromosomally integrated human herpesvirus 6A in a patient with X-linked severe combined immunodeficiency | Q42216350 | ||
| Human herpesvirus 6 (HHV-6) is transmitted from parent to child in an integrated form and characterization of cases with chromosomally integrated HHV-6 DNA. | Q42628382 | ||
| Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients | Q43843926 | ||
| Selective reactivation of human herpesvirus 6 variant a occurs in critically ill immunocompetent hosts | Q44282119 | ||
| Clinical significance of pretransplant chromosomally integrated human herpesvirus-6 in liver transplant recipients. | Q53243888 | ||
| Transmission of integrated human herpesvirus 6 through stem cell transplantation: implications for laboratory diagnosis. | Q53633777 | ||
| The Shortest Telomere, Not Average Telomere Length, Is Critical for Cell Viability and Chromosome Stability | Q56508014 | ||
| Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation | Q80001093 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1062-1069 | |
| P577 | publication date | 2017-06-08 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Outcomes of hematopoietic cell transplantation using donors or recipients with inherited chromosomally integrated HHV-6. | |
| P478 | volume | 130 |
| Q91782357 | Chromatin Profiles of Chromosomally Integrated Human Herpesvirus-6A |
| Q92035579 | Clinical promise of next-generation complement therapeutics |
| Q91693125 | Comparative Analysis of Roseoloviruses in Humans, Pigs, Mice, and Other Species |
| Q52648412 | Comparative genomic, transcriptomic, and proteomic reannotation of human herpesvirus 6. |
| Q52680812 | Copy Number Heterogeneity, Large Origin Tandem Repeats, and Interspecies Recombination in Human Herpesvirus 6A (HHV-6A) and HHV-6B Reference Strains. |
| Q94522049 | Fetal inheritance of chromosomally integrated human herpesvirus 6 predisposes the mother to pre-eclampsia |
| Q92993210 | Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation |
| Q39411655 | HHV-6A/B Integration and the Pathogenesis Associated with the Reactivation of Chromosomally Integrated HHV-6A/B. |
| Q90369398 | Human herpesvirus 6 in transplant recipients: an update on diagnostic and treatment strategies |
| Q38652772 | Latency, Integration, and Reactivation of Human Herpesvirus-6. |
| Q89092987 | Possible reactivation of chromosomally integrated human herpesvirus 6 after treatment with histone deacetylase inhibitor |
| Q59351012 | RNA sequencing of the i human herpesvirus 6B transcriptome to identify targets for clinical assays distinguishing between latent and active infections |
| Q59350258 | Viral Proteins U41 and U70 of Human Herpesvirus 6A Are Dispensable for Telomere Integration |
| Q64375081 | Virus detection in the cerebrospinal fluid of hematopoietic stem cell transplant recipients is associated with poor patient outcomes: a CIBMTR contemporary longitudinal study |
Search more.